Imagine you are analyzing an Indian IT mid-cap firm contemplating a capital raise via an American Depository Receipt (ADR) program. As you review the board’s proposal, you realize the firm is opting for a ‘sponsored’ program, meaning they will directly partner with a U.S. depositary bank. Your task is to adjust your valuation model to account for the heightened disclosure and listing requirements inherent in this choice.
Unlike unsponsored programs, which can emerge without the issuer’s direct involvement, a sponsored program signals a deliberate strategy to attract institutional capital, requiring the company to meet stringent reporting standards mandated by the host exchange.
In practical terms, the listing of a sponsored DR requires the issuer to enter into a formal deposit agreement and ensure the underlying shares are registered with the relevant regulators, such as the SEC in the United States. For a research analyst, this is a critical inflection point in the company’s lifecycle. It implies a transition toward greater transparency, as the firm must align its financial reporting with international accounting standards, often leading to improved price discovery and increased liquidity.
You must account for the costs associated with these requirements, as they impact the issuer’s operating expenses and potentially affect your forward-looking earnings estimates.
Consider the case of an Indian manufacturing giant that previously traded on the domestic exchange but sought a sponsored Level 2 or Level 3 listing in New York. By choosing the sponsored route, the company essentially ‘buys’ global visibility in exchange for the rigors of compliance.
As an analyst, you look for the ’listing premium’—the potential for the stock to command a higher valuation due to expanded access to global investors—while balancing it against the regulatory risk and the increased administrative burden on the management team. You are essentially gauging whether the benefits of global equity access outweigh the governance costs of maintaining the DR facility.
Understanding these listing requirements is not merely a legal detail; it is a fundamental shift in the company’s investment thesis. When you write your recommendation report, you must clearly distinguish between a company that is merely accessible to foreign investors and one that has committed to the sponsored DR structure. This structural commitment acts as a credible signal of corporate governance standards, which in turn influences the risk-adjusted discount rate you might apply in your valuation model.
Mastering these definitions ensures you can parse the difference between market noise and a genuine shift in shareholder value.
Nuance
Check Your Understanding
An Indian company decides to launch a Sponsored Level 1 ADR program. Which of the following is a primary requirement they must fulfill as part of the listing process?
How does the ‘sponsored’ nature of a Depository Receipt affect the role of the issuer compared to an ‘unsponsored’ program?
This is a companion read for Section 2.2 — Product Definitions / Terminology from PASS Research Analyst Certification Examination by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.